Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds
Clinical trial NCT04240886 · TERMINATED
Trial details
- NCT number
- NCT04240886
- Sponsor
- Basilea Pharmaceutica
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-04
- Primary completion
- 2022-03-29
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.